Annals of Colorectal Research

Published by: Kowsar

An Unusual Case of Squamoid Eccrine Carcinoma of the Abdominal Wall with Inguinal Nodal Metastases: A Case Report and Review of the Literature

Brenna L. Hennessey 1 , Logan S. Schwarzman 2 , Dorotea Mutabdzic 3 , Sameer A. Patel 4 , Anthony J. Olszanski 5 , Shelly B. Hayes 6 , Hong Wu 7 , Joshua E. Meyer 6 and Sanjay Reddy 8 , *
Authors Information
1 University of the Sciences, Philadelphia, United States
2 College of Medicine, University of Illinois at Chicago, Chicago, United States
3 Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, United States
4 Division of Plastic and Reconstructive Surgery, Fox Chase Cancer Center, Philadelphia, United States
5 Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, United States
6 Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, United States
7 Department of Pathology, Fox Chase Cancer Center, Philadelphia, United States
8 Department of Surgical Oncology, Philadelphia, United States
Article information
  • Annals of Colorectal Research: 7 (1); e83511
  • Published Online: March 16, 2019
  • Article Type: Case Report
  • Received: August 20, 2018
  • Revised: February 27, 2019
  • Accepted: March 8, 2019
  • DOI: 10.5812/acr.83511

To Cite: Hennessey B L, Schwarzman L S , Mutabdzic D , Patel S A , Olszanski A J, et al. An Unusual Case of Squamoid Eccrine Carcinoma of the Abdominal Wall with Inguinal Nodal Metastases: A Case Report and Review of the Literature , Ann Colorectal Res. Online ahead of Print ; 7(1):e83511. doi: 10.5812/acr.83511.

Abstract
Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Footnotes
References
  • 1. Riera-Leal L, Guevara-Gutierrez E, Barrientos-Garcia JG, Madrigal-Kasem R, Briseno-Rodriguez G, Tlacuilo-Parra A. Eccrine porocarcinoma: Epidemiologic and histopathologic characteristics. Int J Dermatol. 2015;54(5):580-6. doi: 10.1111/ijd.12714. [PubMed: 25515648].
  • 2. Yugueros P, Kane WJ, Goellner JR. Sweat gland carcinoma: A clinicopathologic analysis of an expanded series in a single institution. Plast Reconstr Surg. 1998;102(3):705-10. doi: 10.1097/00006534-199809010-00014. [PubMed: 9727435].
  • 3. Choi SH, Kim YJ, Kim H, Kim HJ, Nam SH, Choi YW. A rare case of abdominal porocarcinoma. Arch Plastic Surg. 2014;41(1):91. doi: 10.5999/aps.2014.41.1.91.
  • 4. Ramasenderan N, Shahir H, Omar SZ. A synchronous incidence of eccrine porocarcinoma of the forearm and facial squamous cell carcinoma: A case report. Int J Surg Case Rep. 2018;42:116-20. doi: 10.1016/j.ijscr.2017.11.066. [PubMed: 29245095]. [PubMed Central: PMC5730414].
  • 5. Rehal B, Merin MR, Barr K. Metastatic eccrine porocarcinoma. Cutis. 2013;92(2):67-70. [PubMed: 24087778].
  • 6. Blake PW, Bradford PT, Devesa SS, Toro JR. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: A population-based study. Arch Dermatol. 2010;146(6). doi: 10.1001/archdermatol.2010.105.
  • 7. Wick MR, Goellner JR, Wolfe JT, Su WPD. Adnexal carcinomas of the skin I. Eccrine carcinomas. Cancer. 1985;56(5):1147-62. doi: 10.1002/1097-0142(19850901)56:5<1147::aid-cncr2820560532>3.0.co;2-3.
  • 8. Song SS, Wu Lee W, Hamman MS, Jiang SI. Mohs micrographic surgery for eccrine porocarcinoma: An update and review of the literature. Dermatol Surg. 2015;41(3):301-6. doi: 10.1097/DSS.0000000000000286. [PubMed: 25742554].
  • 9. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and paget's dermatosis. Arch Dermatol. 1963;88:597-606. doi: 10.1001/archderm.1963.01590230105015. [PubMed: 14060075].
  • 10. Choi CM, Cho HR, Lew BL, Sim WY. Eccrine porocarcinoma presenting with unusual clinical manifestations: A case report and review of the literature. Ann Dermatol. 2011;23 Suppl 1:S79-83. doi: 10.5021/ad.2011.23.S1.S79. [PubMed: 22028580]. [PubMed Central: PMC3199430].
  • 11. Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: Clinical and pathological studies of 12 cases. J Dermatol. 2007;34(8):516-22. doi: 10.1111/j.1346-8138.2007.00324.x. [PubMed: 17683381].
  • 12. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): A clinicopathologic study of 69 cases. Am J Surg Pathol. 2001;25(6):710-20. doi: 10.1097/00000478-200106000-00002. [PubMed: 11395548].
  • 13. Urso C, Bondi R, Paglierani M, Salvadori A, Anichini C, Giannini A. Carcinomas of sweat glands: Report of 60 cases. Arch Pathol Lab Med. 2001;125(4):498-505. doi: 10.1043/0003-9985(2001)125<0498:COSG>2.0.CO;2. [PubMed: 11260623].
  • 14. Mahalingam M, Richards JE, Selim MA, Muzikansky A, Hoang MP. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. Hum Pathol. 2012;43(8):1265-72. doi: 10.1016/j.humpath.2011.10.005. [PubMed: 22285043].
  • 15. Shaw M, McKee PH, Lowe D, Black MM. Malignant eccrine poroma: A study of twenty-seven cases. Br J Dermatol. 1982;107(6):675-80. doi: 10.1111/j.1365-2133.1982.tb00527.x. [PubMed: 6293528].
  • 16. Perna C, Cuevas J, Jimenez-Heffernan JA, Hardisson D, Contreras F. Eccrine porocarcinoma (malignant eccrine poroma). Am J Surg Pathol. 2002;26(2):272-4. doi: 10.1097/00000478-200202000-00019. [PubMed: 11812953].
  • 17. Vleugels FR, Girouard SD, Schmults CD, Ng AK, Russell SE, Wang LC, et al. Metastatic eccrine porocarcinoma after Mohs micrographic surgery: A case report. J Clin Oncol. 2012;30(21):e188-91. doi: 10.1200/JCO.2011.40.6843. [PubMed: 22689795].
  • 18. Martinez SR, Barr KL, Canter RJ. Rare tumors through the looking glass: An examination of malignant cutaneous adnexal tumors. Arch Dermatol. 2011;147(9):1058-62. doi: 10.1001/archdermatol.2011.229. [PubMed: 21931043].
  • 19. Mahomed F, Blok J, Grayson W. The squamous variant of eccrine porocarcinoma: A clinicopathological study of 21 cases. J Clin Pathol. 2008;61(3):361-5. doi: 10.1136/jcp.2007.049213. [PubMed: 17704263].
  • 20. Kim JW, Oh DJ, Kang MS, Lee D, Hwang SW, Park SW. A case of metastatic eccrine porocarcinoma. Acta Derm Venereol. 2007;87(6):550-2. doi: 10.2340/00015555-0310. [PubMed: 17989901].
  • 21. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol. 1992;27(2 Pt 2):306-11. doi: 10.1016/0190-9622(92)70187-K. [PubMed: 1325487].
  • 22. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw. 2010;8(8):836-64. doi: 10.6004/jnccn.2010.0062. [PubMed: 20870631].
  • 23. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy. Ann Oncol. 2001;12(3):411-4. doi: 10.1023/A:1011196615177. [PubMed: 11332156].
  • 24. de Bree E, Volalakis E, Tsetis D, Varthalitis Y, Panagiotidis J, Romanos J, et al. Treatment of advanced malignant eccrine poroma with locoregional chemotherapy. Br J Dermatol. 2005;152(5):1051-5. doi: 10.1111/j.1365-2133.2005.06472.x. [PubMed: 15888170].
  • 25. Khaled H, Hassan RA. Metastatic eccrine porocarcinoma respond to combination chemotherapy docetaxel, cisplatin and infusion 5 fu with long disease control. Am J Cancer Case Rep. 2015;3(1):6-11.
  • 26. Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: A multicentre, single-group, open-label, phase 2 trial. The Lancet Oncology. 2016;17(10):1374-85. doi: 10.1016/s1470-2045(16)30364-3.
  • 27. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164-72. doi: 10.1056/NEJMoa0905360. [PubMed: 19726763].
  • 28. Lipson EJ, Bagnasco SM, Moore JJ, Jang S, Patel MJ, Zachary AA, et al. Tumor regression and allograft rejection after administration of anti-pd-1. N Engl J Med. 2016;374(9):896-8. doi: 10.1056/NEJMc1509268. [PubMed: 26962927]. [PubMed Central: PMC4850555].
  • 29. Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and adjuvant radiation for high-risk skin adnexal carcinoma of the head and neck. Am J Clin Oncol. 2017;40(4):429-32. doi: 10.1097/COC.0000000000000178. [PubMed: 25599317]. [PubMed Central: PMC4504824].
  • 30. Fujimine-Sato A, Toyoshima M, Shigeta S, Toki A, Kuno T, Sato I, et al. Eccrine porocarcinoma of the vulva: A case report and review of the literature. J Med Case Rep. 2016;10(1):319. doi: 10.1186/s13256-016-1106-1. [PubMed: 27832810]. [PubMed Central: PMC5105286].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments